Hyperinsulinemia and Insulin Resistance in Hypertension: Differential Effects of Antihypertensive Agents

References

• Stamler J., Wentworth D., Vaccaro O., Neaton J. D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16: 434–444
   PubMed Web of Science ®Google Scholar
• Reaven G. M. Role of insulin resistance in human disease. Banting Lecture. Diabetes 1988; 37: 1595–1607
   PubMed Web of Science ®Google Scholar
• Rosenstok J., Raskin P. Early diabetic nephropathy assessment and potential interventions. Diabetes Care 1986; 9: 529–531
   PubMed Web of Science ®Google Scholar
• Knowler W. C., Bennett P. H., Ballintine E. J. Increased incidence of retinopathy in diabetics with elevated blood pressure. N. Engl J Med 1980; 302: 645–647
   PubMed Web of Science ®Google Scholar
• MacMohan S., Peto R., Cutler J., Colliffs R., Sorthe P., et al. Blood pressure stroke and coronary heart disease. Lancet 1990; 335: 765–774
   PubMed Web of Science ®Google Scholar
• Zatz R., Dunn B. R., Meyer T. W. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986; 77: 1925–1930
   PubMed Web of Science ®Google Scholar
• Kuller L. H., Dorman J. S., Wolf P. A. Cerebrovascular disease and diabetes. Diabetes in America (85–468): US Dept of Health and Human Services. 1985; 1–18
   Google Scholar
• Fuh MM-T, Sheith S-M, Wu D. A., Chen I., Reaven G. M. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch Intern Med. 1987; 147: 1035–1038
   PubMed Web of Science ®Google Scholar
• Kannel W. B. Lipids diabetes and coronary heart disease: Insight from the Framingham Study. Am Heart J. 1985; 110: 1100–1107
   PubMed Web of Science ®Google Scholar
• Rodrigues B., Goyal R. K., McNeill J. H. Effects of hydralazine on STZ induced diabetic rats - prevention of hyperlipidaemia and improvement in cardiac function. J Pharmac Expt Ther 1986; 237: 299–307
   Google Scholar
• Goyal R. K., Bangaru R. A., Lakkad N. B., Rao M. V. Effect of chronic treatment with atenolol and prazosin in streptozotocin induced diabetic rats. Ind J Physiol Pharmacol. 1996; 40(3)220–224
   PubMedGoogle Scholar
• Goyal R. K., Lakkad N. B., Rao M. V. Effects of chronic treatment with enalapril on streptozotocin-induced diabetic rats. Pharmacol Rev Comm. 1997; 9: 133–139
   Google Scholar
• Shah T. S., Sana M. C., Gandhi T. P., Bangaru R. A., Goyal R. K. Effects of chronic nifedipine treatment on streptozotocin-induced diabetic rats. J Cardiovasc Pharmacol. 1995; 26: 6–12
   PubMed Web of Science ®Google Scholar
• Damani R. C., Satia M. C., Goyal R. K. Beneficial effects of clonidine in streptozotocin induced diabetes and DOCA hypertensive rats. J Pharm Pharmacol 1997; 49: 1030–1035
   PubMed Web of Science ®Google Scholar
• Bangaru R. A., Lakkad N. B., Goyal R. K. Effect of chronic atenolol treatment on diabetes induced cardiac depression and other complications. Ind J Physiol Pharmacol. 1996; 40: 220–224
   PubMedGoogle Scholar
• Joshi S. S., Shah T. S., Goyal R. K. Effects of chronic treatment with nitrendipine in streptozotocin-induced diabetic rats. Ind J Pharm Sci. 1996; 58(3)100–105
   Google Scholar
• Hakim Z. S., Patel B. K., Goyal R. K. Effects of chronic ramipril treatment in streptozotocin-induced diabetic rats. Ind J Physiol Pharmacol 1997; 41(4)353–360
   PubMedGoogle Scholar
• Kawashima H. Chronic hypertension induced by ITZ in rats. Naunyn Schiemedberg Arch Pharmacol. 1978; 305: 123–126
   Google Scholar
• Hayashi M., Senba S., Saito I. Changes in blcxxl pressure, urinary kallikrien, and urinary prostaglandin Ej in rats with STZ induced diabetes. Naunyn Schimedbergs Arch Pharmacol. 1983; 322: 290–294
   PubMed Web of Science ®Google Scholar
• Funakawa S. Renin angiotensin system and prostacyclin biosynthesis in STZ diabetic rats. Eur J Pharmacol. 1983; 94: 27–33
   PubMed Web of Science ®Google Scholar
• Kusaka M., Kishi K., Sokabe H. Does so-called streptozotocin hypertension exists in rats?. Hypertens 1987; 10: 517–521
   PubMed Web of Science ®Google Scholar
• Hebden R. A., Todd M. E., Tnag C., Gowen B., McNeill J. H. Association of DOCA hypertension with induction of atherosclerosis in rats with short-term diabetes-mellitus. Am J Physiol. 1990; 251: F563–F575
   Google Scholar
• Sevak A. R., Goyal R.K. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin-induced diabetic and DOCA hypertensive rats. Pharm Res 1996; 34: 210–209
   Google Scholar
• Dia S., McNeill J. H. Myocardial performance of streptozotocin diabetic and DOCA-hypertensiverats. Am J Physiol. 1992; 263: H1798–H1805
   Google Scholar
• Collins W. C. J., Cullen M. J., Feely J. Calcium channel blocker drugs and diabetic control. Clin Pharmacol Pher. 1987; 42: 420–423
   Web of Science ®Google Scholar
• Tebtorio A., Ghilardi G., Pedroncelli A., Benco R., Stroppa S., et al. Insulin secretion and glucose tolerance in non-insulin dependent diabetic patients after chronic nifedipine treatment. Eur J Clin Pharmacol. 1989; 36: 311–313
   PubMed Web of Science ®Google Scholar
• Reaven G. M. Insulin resistance, hyperinsulinemia and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med. 1991; 907S–12S
   Google Scholar
• Christensen C. K., Krussad L. R., Mongensen C. E. Increased blood pressure in diabetes: Essential hypertension or diabetic nephropathy?. Sand J Clin Lab Invest 1987; 47: 363–370
   PubMed Web of Science ®Google Scholar
• DeFronzo R. A., Cooke C. R., Andres R., Falona G. R., Davis P. J. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate, in man. J Clin Invest. 1975; 55: 845–855
   PubMed Web of Science ®Google Scholar
• Cruz A. B., Amatuzio D. S., Grande F., Hay L. J. Effect of intra arterial insulin on tissue cholesterol and fatty acids in alloxan diabetic dogs. Circ Res 1961; 9: 39–43
   PubMed Web of Science ®Google Scholar
• Pfeifle B., Ditschuneit H. Effect of insulin on the growth of cultured arterial smooth muscle cells. Diabetologia 1981; 20: 155–158
   PubMed Web of Science ®Google Scholar
• Hulman S., Falkner B., Chen Y. Q. Insulin resistance in the spontaneously hypertensive rat. Metabolism 1991; 40: 359–361
   PubMed Web of Science ®Google Scholar
• Cadihac M., Guidicelli J. F. Myocardial and vascular effects of perindopril, a new converting enzyme inhibitor, during hypertension development in SHR. Arch Inter de Pharmacodyn et de ther 1986; 284: 116–126
   Google Scholar
• Christensen K. L., Jerpersen L. T., Mulvany M. J. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long term treatment related to vascular structure. J Hypertens. 1989; 7: 83–90
   PubMed Web of Science ®Google Scholar
• Buchanan T. Z., Sipos G. F., Madrilejo N., Chaplin L., Campese V. M. Hypotension without peripheral insulin resistance in spontaneously hypertensive rats. Am J Physiol. 1992; 262: E14–E19
   Google Scholar
• Frontoni S., Ohman L., Haywood J. R., DeFronzo R. A., Rossetti L. In vivo insulin action in genetic models of hypertension. Am J Physiol. 1992; 262: E191–E196
   PubMed Web of Science ®Google Scholar
• Srinivasan P. S., Hakim Z. S., Santani D. D., Goyal R. K. Effect of chronic treatment with amlodipine in streptozotocin-diabetic and spontaneously hypertensive rats. Pharm Res 1997; 31(1)1–6
   Google Scholar
• Parulekar A. A., Srinivasan P. S., Hakim Z. S., Santani D. D., Goyal R. K. Spirapril attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats. Ind J Hypertens. 1996; 1: 8–10
   Google Scholar
• Shenoy A. G., Reddy C. K., Santani D. D., Goyal R. K. Effects of chronic treatment with perindopril on insulin sensitivity and cardiovascular parameters in spontaneously hypertensive and streptozotocin-diabetic rats. Pharmacol Res 1998, in press
   Web of Science ®Google Scholar
• Mehta A. A., Patel S., Santani D. D., Goyal R. K. Effect of nifedipine and enalapril on insulin-induced glucose disposal in spontaneously hypertensive and diabeticrats. Clin Exp Hypertens. 1998, in press
   Google Scholar
• Weir G. C., Clore E. T. Islet secretion in a new experimental model of NIDDM. Diabetes 1981; 30: 590–595
   PubMed Web of Science ®Google Scholar
• Gokhale M. S., Shah D. H., Hakim Z. S., Santani D. D., Goyal R. K. Effects of chronic treatment with amlodipine in non-insulin dependent diabetic rats. Pharm Res., in press
   Google Scholar
• Satia M. C., Shukla M. L., Gandhi T. P., Goyal R. K. Prevalence of hypertension and comparative evaluation of four antihypertensives monotherapy in Indian NIDDM hypertensive patients. Ind J Hypertens 1997; 2: 17–27
   Google Scholar
• Satia M. C., Shukla M. L., Goyal R. K. Effects of enalapril on lipid profile in diabetic and non-diabetic essential hypertensive patients. Ind J Physiol Pharmacol. 1996; 40: 83–86
   PubMedGoogle Scholar